JP2020127419A5 - - Google Patents

Download PDF

Info

Publication number
JP2020127419A5
JP2020127419A5 JP2020081545A JP2020081545A JP2020127419A5 JP 2020127419 A5 JP2020127419 A5 JP 2020127419A5 JP 2020081545 A JP2020081545 A JP 2020081545A JP 2020081545 A JP2020081545 A JP 2020081545A JP 2020127419 A5 JP2020127419 A5 JP 2020127419A5
Authority
JP
Japan
Prior art keywords
analog
seq
shk
analog according
toxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020081545A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020127419A (ja
JP6953579B2 (ja
Filing date
Publication date
Priority claimed from JP2017508102A external-priority patent/JP6847828B2/ja
Application filed filed Critical
Publication of JP2020127419A publication Critical patent/JP2020127419A/ja
Publication of JP2020127419A5 publication Critical patent/JP2020127419A5/ja
Application granted granted Critical
Publication of JP6953579B2 publication Critical patent/JP6953579B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020081545A 2014-08-15 2020-05-01 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用 Active JP6953579B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2014903189A AU2014903189A0 (en) 2014-08-15 Novel potassium channel blockers
AU2014903189 2014-08-15
JP2017508102A JP6847828B2 (ja) 2014-08-15 2015-08-14 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017508102A Division JP6847828B2 (ja) 2014-08-15 2015-08-14 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用

Publications (3)

Publication Number Publication Date
JP2020127419A JP2020127419A (ja) 2020-08-27
JP2020127419A5 true JP2020127419A5 (enExample) 2020-11-12
JP6953579B2 JP6953579B2 (ja) 2021-10-27

Family

ID=55303691

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017508102A Active JP6847828B2 (ja) 2014-08-15 2015-08-14 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用
JP2020081545A Active JP6953579B2 (ja) 2014-08-15 2020-05-01 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017508102A Active JP6847828B2 (ja) 2014-08-15 2015-08-14 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用

Country Status (5)

Country Link
US (1) US10246496B2 (enExample)
EP (1) EP3180365B1 (enExample)
JP (2) JP6847828B2 (enExample)
AU (1) AU2015303825B2 (enExample)
WO (1) WO2016023072A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015303825B2 (en) * 2014-08-15 2021-01-14 Baylor College Of Medicine Novel potassium channel blockers and use thereof in the treatment of autoimmune diseases
KR102533290B1 (ko) * 2022-04-14 2023-05-16 한국해양과학기술원 전압개폐 칼륨이온채널 억제 활성능을 갖는 펩타이드
KR102553070B1 (ko) * 2022-06-16 2023-07-07 한국해양과학기술원 전압개폐 칼륨이온채널 억제 활성능을 갖는 작은상자해파리 기원 펩타이드

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101072577B (zh) 2004-10-07 2013-12-18 加利福尼亚大学董事会 ShK毒素类似物及其在选择性抑制Kv1.3钾通道中的应用
PE20081140A1 (es) 2006-10-25 2008-09-22 Amgen Inc Agentes terapeuticos a base de peptidos derivados de toxinas
CA2686216C (en) * 2007-05-14 2016-04-12 Universidad Nacional Autonoma De Mexico Vm23 and vm24, two scorpion peptides that block human t-lymphocyte potassium channels (sub-type kv1.3) with high selectivity and decrease the in vivo dth-responses in rats
WO2010108154A2 (en) 2009-03-20 2010-09-23 Amgen Inc. Selective and potent peptide inhibitors of kv1.3
KR20140038501A (ko) * 2011-06-06 2014-03-28 키네타 원, 엘엘씨 Shk-기초된 제약학적 조성물 및 이들을 제조하고 이용하는 방법
EA037308B1 (ru) * 2013-01-25 2021-03-10 Янссен Байотек, Инк. ВЫДЕЛЕННЫЙ ПЕПТИДНЫЙ АНТАГОНИСТ ПОТЕНЦИАЛ-ЗАВИСИМОГО КАЛИЕВОГО КАНАЛА Kv1.3
AU2015303825B2 (en) * 2014-08-15 2021-01-14 Baylor College Of Medicine Novel potassium channel blockers and use thereof in the treatment of autoimmune diseases

Similar Documents

Publication Publication Date Title
JP2020127419A5 (enExample)
JP2018138049A5 (enExample)
SA522433360B1 (ar) L-أَسْباراجيناز مُعدل
JP2017018125A5 (enExample)
JP2019122392A5 (enExample)
JP2020518268A5 (enExample)
JP2004267216A5 (enExample)
JP2006516189A5 (enExample)
JP2009527226A5 (enExample)
JP2013027391A5 (enExample)
NZ603348A (en) Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
JP2009268467A5 (enExample)
JP2024028452A5 (enExample)
JP2020517260A5 (enExample)
JP2019534884A5 (enExample)
JP2017221201A5 (enExample)
JP2018537089A5 (enExample)
JP2003530124A5 (enExample)
JP2011521661A5 (enExample)
JP2008545393A5 (enExample)
JP2017513849A5 (enExample)
JP2002517193A5 (enExample)
CA2202519A1 (en) Cloning, expression and characterization of a new form of phosphatidylinositol-3-kinase
IL209595A (en) Isolated nucleic acid, expression vector and host cell containing it, isolated polypeptide encoded by it and chimeric polypeptide containing it, process for preparation, oligopeptide hhipl l2 mimics loop, preparations containing it and methods for its production
JP2006158399A5 (ja) 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤